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INTRODUCTION 
 
 
Meant to be safer, harmless and having no-tobacco, the 
Electronic cigarette (e-cigarette) was first patented in 
1967 by Herbert A. Gilbert from Beaver Falls, PA.1  They 
gained immense popularity after a Chinese pharmacist 
named Hon Lik introduced e-cigarettes in the Chinese 
market through his employer in 2004 and ever since, 
are freely available over the internet for users to buy and 
use.2 
 
These (e-cigarettes) are also commonly known as 
Electronic Nicotine Delivery Systems (ENDS) and is a 
product which is operated through a battery which 
helps deliver nicotine through inhalable aerosol 
generated from a nicotine-containing solution. The 
term “vaping” is associated with an e-cigarette use. 
Vaping is finding an increase in its use, especially 
among the young population as it gives a sensation as 
well as provides the same taste and feeling of inhaling 
smoke that mimicking smoking from paper cigarettes.  
Not just e-cigarettes, but vape pens and advanced 
personal vaporisers (MODS) too are the devices used 
for vaping. 
 
They were initially used as an alternative to regular 
smoking and were initially considered safe to use. 
However, the health consequences, arising from the 
long-term use of these e-cigarettes, i.e. (1) Its efficacy as  
 
 
compared to combustible cigarette smokers to help 
them to reduce and/or stop smoking, (2) The extent of 
carcinogens in e-cigarettes and, (3) the role of these 
products in initiating and perpetuating nicotine 
dependence in teenagers and young adults has been 
debated constantly across the globe.3 
 
There have been various cases reported of lung injury 
as a result of these e-cigarettes and in this context, on 
October 11th, 2019,4 The Centres for Disease Control and 
Prevention (CDC) in its morbidity and mortality weekly 
report issued  have given an official name to the vaping 
related illness named: EVALI (E-cigarette or Vaping 
Product Associated Lung Injury). This review paper 
discusses about e-cigarettes and about its harmful 
effects that lead to EVALI in a person. 
 
WHAT IS AN E- CIGARETTE? 
An E- cigarette  is a hand held powered vaporizer which 
includes hand to mouth action of smoking but without 
combustion of tobacco and are categorised in to three 
groups: disposable, rechargeable and modular.5 They 
have a battery powered vaporizer that uses a heating 
element to heat e-liquid, typically containing nicotine, 
from a cartridge that produces a chemical filled aerosol. 
The effectiveness of an e-cigarettes depends on a variety 
of factors which include battery strength, the nature of  
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the circuit used, solutions/flavour used and the user’s 
smoking behaviour, among others. Since they work by 
producing vapours, their effectiveness has a direct 
dependence on the product’s competence to heat the 
solution into a state where it transforms into vapour. As 
a result, the battery’s voltage and circuit strength are 
also crucial components. The stronger the voltage and 
circuit, faster will the solution heat up and vaporise, and 
more effective will be the product. Electronic Smoking 
Device aerisol (ESD) that operate using a single coil 
heating element produce much higher levels of toxins 
at higher temperatures than double-coil devices across 
different e-liquids that produce aerosol at lower 
temperatures.6 
 
E-cigarettes contain nicotine cartridges with airflow 
sensors, but do not burn tobacco.7 Many e-liquids or e-
juice comes in fruit flavours, making them appealing to 
kids. There are over 466 brands and 7764 unique 
flavours with about 242 new flavours added per 
month.8 Instead of cigarette smoke, the user inhales as 
an aerosol, commonly called vapour.9  
 
MARKET SHARE OF VAPE PRODUCTS 
As per a report, the number of vapers have alarmingly 
increased from 7 million (2011) to 41 million (2018). The 
FDA in 2018 reported that approximately 3.62 million 
students users belonged to middle and high schools in 
the USA itself. With a span of one year, the current e-
cigarette use (use on at least one day in the past 30 days) 
in the same study population increased from 11.7 to 20.8 
percent.10 
 
It has also been estimated that the number of adults 
who vape will reach almost 55 million by the year 2021 
and the global market currently is estimated to be 
worth $19.3 bn which is approximately three times 
higher as compared to $6.9 bn five years ago. USA has 
the largest market share of vape products followed 
closely by UK. Market estimates have suggested that in 
2014, there were at least 466 brands producing e-
cigarettes and by 2030 the global e-cigarette market 
would rise by 17 times. 
 
MARKET SHARE IN INDIA 
India has more than ten 100 million adult smokers, 
making it a huge lucrative and a potential market for e-
cigarette companies. A single disposable e-cigarettes 
ranges from $6 to $12 (INR 390-782) and the cartridge 
models are rechargeable and contain pre-filled 
cartridges starter kits, which usually range around $40 
to $ 60 (INR 2600-3900).12  In India, there are 75 
companies that were supplying these e-cigarettes on 
line. During 2015-16 to 2018-19 e-cigarettes worth 
$1,91,781 were imported in India which were mostly 
imported from China, US, Hong Kong and Germany.  
 
EVALI: THE PROBABLE CULPRITS 
To educate vapers, Dr. Stanton Glantz, Director for the 
Center for Tobacco Control Research and Education at 
the University of California, San Francisco stated that 
“If you are somebody who is using an e-cigarette, you are 
breathing an aerosol of exhaled nicotine, ultra fine 
particles,volatile organic compounds and other toxins”.14 
 
An Electronic Smoking Device aerosol (ESD) is made up 
of high concentration of ultrafine particles and the 
particle concentration is higher than in conventional 
tobacco cigarette smoke.13 Exposure to fine and 
ultrafine particles may exacerbate respiratory ailments 
like asthma and constrict arteries which could trigger a 
heart attack.14 The compounds that have been 
identified in mainstream (MS) or second hand (SS) ESD 
aerosol include: Actaldehyde(MS), Benzene(SS), 
Cadmium(MS), Formaldehyde(MS,SS), Isoprene(SS), 
Lead (MS), Nickel(MS), Nicotine (MS,SS), N-
Nitrosonornicotin (MS,SS) and Toluene(MS,SS). Short 
term exposure of propelene glycol a chemical that is 
used as a base in ESD solution and is one of the primary 
component in aerosol emitted by ESD causes eye, 
throat and airway irritation, whereas long term 
exposure can result in children developing asthma.15 
 
Henderson TR et al. (1981)16 reported that heating 
propylene glycol changes its chemical composition and 
produces small amount of propylene oxide, a known 
carcinogen. Detectable levels of nitrosamines, 
diethylene glycol, glycerol, propanal, diactin and 
triactine have been reported in ESD aerosol.17,18 Short 
term use of ESD has been shown to increase respiratory 
resistance and impair lung function, which may result 
in difficult breathing19  reported that ESD exposure 
especially to cinnamon damages lung tissues due to 
increased oxidative stress and inflammatory responses. 
Toxic chemicals attached to nanoparticles in ESD 
aerosol that are much smaller than the particle size in 
tobacco  have adverse health effects than when these 
toxins are attached to large tobacco smoke particles.20 
 
CAUSES  OF  EVALI 
Since not much is known about the real cause of EVALI 
right now, it is believed that it might be an overlap with 
smoking related injuries or it might be a completely 
different phenomenon. However, the only difference 
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was that many of the individuals who reported with the 
condition exclusively used vaping products and were 
not smoking the conventional cigarettes. 
 
Officials at the CDC said that THC 
(Tetrahydrocannabinol) containing products may be 
behind this outbreak in lung illness related to vaping. 
THC is the key psychoactive compound that is found in 
marijuana which in turn is responsible for the feeling of 
being high. Around 16 percent of the sick patients 
claimed that they had used products that contained 
nicotine but not THC whereas 77 percent claimed of 
using products containing a mix of both.21 The CDC 
even has reported that these THC – containing products  
were obtained from informal sources like friends,  
family, or directly from the drug dealers (in Illinois and 
Wisconsin). 
 
Another possible culprit that the CDC believes, which 
could be responsible for such chemical exposure rather 
than an infection has been identified as Vitamin E 
acetate.21 Vitamin E acetate is a nutritional supplement 
that can be ingested as a vitamin supplement, or 
applied to the skin and is not know of causing any harm, 
however it is not approved as a vaping additive by New 
York State Medical Marijuana Program. The New York 
State Department of Health, after its thorough 
investigation stated that nearly all cannabis containing 
samples contained very high levels of this compound 
and no such traces were found in nicotine containing 
samples.21 CDC is keeping an eye and still investigating 
the oil like compound which could be a possible culprit 
of EVALI. 
 
CASES REPORTED  OF  EVALI 
CDC, U.S Food and Drug administration (FDA), all 
state and the local health departments, and other 
clinical and public health sectors are investigating a 
multistate outbreak of the lung injury associated with 
e-cigarette, or vaping products. January 21st, 2020 2051 
cases have been reported from all 50 states with 60 
deaths confirmed in 27 states and the district of 
Columbia. Such an increase in the number of cases as 
well as mortality is the reason that CDC and other 
governmental agencies are directing their effort to 
prevent EVALI by either banning the ENDS or 
educating the public regarding the harmful effects of 
vaping.   
 
As per CDC, approximately 90 percent of the cases that 
were reported with symptoms were hospitalized and 
many of them required supplemental oxygen, few of 
them had to be put on ventilator to help breathe  while 
many had to be put on corticosteroids to reduce the 
lung inflammation.  The cases reported with the signs 
and symptoms such as couching, shortness of breath, 
nausea, fatigue, weight, night sweats, low oxygen levels, 
and hazy spots on a lung X-ray.22 Such developments 
can be of  extreme concern as most of the cases reported 
included teenagers or young adults. Some cases were 
characterised by pneumonitis (lung inflammation), 
some with accumulation of oil in the lungs, while others 
involved accumulation of white blood cells.23 
 
INDIAN SCENARIO 
In India till date no cases have been reported of EVALI, 
but that does not signify that the people of India who 
have been vaping are under no threat of developing the 
signs and symptoms of EVALI. The use of e-cigarettes 
prior to the ban by the population was increasing day 
by day and is it quite possible that the subjects 
reporting with symptoms could have been 
underreported by the patients to their attending 
doctors, or could have simply been associated with 
combustible tobacco use. The presence of air pollution 
could have also been a confounding factor (Especially 
in metropolitan areas where the AQIs are quite higher) 
in the proper diagnosis of EVALI and hence, no such 
cases have been reported till date.  
 
MEASURES TAKEN 
CDC is working day and night to identify the cause of 
the outbreak in collaboration with the states and other 
federal agencies. They even have activated the 
Emergency Operations Centre (EOC) to coordinate 
activities and to provide help to states, public health 
partners as well as the clinicians around the nation. By 
invitation the Epidemic Intelligence Service (EIS) 
officers and other CDC staff has been deployed by CDC. 
Few other range of laboratory investigation made 
possible by CDC and FDA include: 
 
• Testing bronchoalveolar lavage (BAL) fluid samples 
along with the urine and blood samples paired to BAL 
fluid samples. 
• Testing the pathological samples, that includes lung 
biopsy or autopsy specimen. 
• Aerosol emission testing which will augment the 
ongoing work of FDA to characterize e-liquid and 
help in better understanding of the lung injury 
breakout. 
• Apart from several laboratory investigations, Ban on 
the use of e-cigarette or other vaping products too 
have been imposed in several states globally. In the US, 
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Michigan has become the first state to impose ban on 
flavoured e-cigarettes, with New York being the 
second state to impose the ban.  
 
INDIA 
A day after New York’s ban, Modi government on 18th 
September,2019 too announced a ban on e-cigarettes 
confirming the health risks they pose to the youth and 
the increasing addiction to be alarming.24 The 
government said ,the main aim  to ban e-cigarettes was  
protecting the youth, the section of the society which is 
most vulnerable to addiction and its health hazards.1 
5states  and one union territory prior to any 
announcement being made , had already banned e-
cigarette which include, Punjab, Karnataka, Mizoram, 
Kerala, Jammu & Kashmir, Uttar Pradesh,  Bihar, 
Maharashtra, Tamil Nadu, Jharkhand, Himachal 
Pradesh, Pondicherry, Rajasthan, Meghalaya, Odisha, 
and Nagaland. 
 
FINES UNDER THE NEW LAW (INDIA) 
Once the law passed in 2019 comes into effect, certain 
provisions will be made applicable.23 The production, 
manufacture, import, export of e-cigarettes shall 
become an identifiable offence in India, which will be 
punished with an imprisonment of up to one year or 
fine up to 1 lakh or both for the first offence. 
 
• The punishment of imprisonment up to 3 years and 
fine up to 5 lac, if someone caught disobeying the law 
again. 
• Punishment of imprisonment up to 6 months or fine 
up to Rs 50,000 for those found storing e-cigarettes. 
• The dealers that have existing stocks of e- cigarettes 
need to inform the nearest police station on their own 
before strict actions are taken against them. 
 
VAPING: AN ETHICAL DILEMMA 
e-cigarettes in the first place were introduced to help 
people quit smoking tobacco. However, there are no 
such studies that show vaping actually helps people quit 
smoking. In 2015 ,U.S surgeon general reported a hike 
in consumption of E-cigarette by 900%, in which 40% 
users had never smoked the traditional cigarette. The 
traditional as well the E –cigarette, both contain 
nicotine and can be equally addictive as cocaine or 
heroin. In fact, few of the e-cigarette users get more 
nicotine than the traditional ones as, extra strength 
cartridges are available which have a higher 
concentration of nicotine or a higher hit of the 
substance can be achieved by increasing the voltage of 
E – cigarette. Vaping is definitely less harmful than 
smoking the traditional cigarette, but still it is not safe. 
Hence electronic cigarettes are not the best smoking 
cessation tools. 
 
PREVENTION OF EVALI 
As vitamin E-Acetate is listed as a possible culprit of 
EVALI ,but evidence is not yet so substantial to rule out 
the contribution of other chemicals that are present in 
an E- Cigarette .Till then the CDC recommends all the 
people to consider refraining themselves from using E –
Cigarette or vaping , products. THC used very often has 
also being associated as another probable cause of 
EVALI ,so the people are recommended not to use THC 
containing E- Cigarettes, vapes, or other products in 
order to avoid any harmful effects it may pose. 
Population with Marijuana use disorder should seek 
medical help as it has other ill effects as well .Adults 
who are not tobacco consumers yet , should not start 
using E-Cigarette as they might consider it to be less 
harmful which is a persistent ethical dilemma in our 
society. Adults who continue to use E-cigarettes should 
keenly monitor themselves for any sort of symptoms 
and get the symptoms checked by a health care 
provider ,if any resemblance found with those reported 
in the outbreak. 
 
Adults using E-Cigarette as tobacco cessation method, 
trying to quit smoking are recommended to quit this 
habit and not going back to smoking the conventional 
ones rather considering using FDA approved nicotine 
replacement therapies. 
 
CONCLUSION 
With the CDC giving a name to the vaping related lung 
injuries, maximum-impact mass awareness programs 
need to be undertaken across the globe. Other 
countries should also report such cases so that 
significant conclusions regarding its aetiology and 
management can be established. If a complete ban is 
not feasible, a health warning among the packs should 
be made mandatory and any new flavour/product 
should only be introduced with necessary regulatory 
approvals so that the mortality and mortality associated 
with  EVALI can be decreased.  
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